Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$428,990,409
-$30,565,915 QoQ
Shares Held
2,262,369
-2.9% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#63
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $3,615,172,375 across 15 Drug Manufacturers - General names. AZN ranks #5 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,593,352 | $668,008,942 | |
| 2 | LLY |
ELI LILLY & Co
|
508,522 | $609,936,593 | |
| 3 | ABBV |
AbbVie Inc.
|
1,901,997 | $478,618,525 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,695,329 | $474,849,776 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
2,262,369 | $428,990,409 | |
| 6 | GSK |
GSK plc
|
6,660,434 | $349,139,950 | |
| 7 | JNJ |
Johnson & Johnson
|
1,361,700 | $345,830,949 | |
| 8 | NVO |
Novo Nordisk A S
|
2,736,697 | $131,197,254 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $428,990,409 | 2,262,369 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $459,556,324 | 2,330,171 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||